Adverse Drug Reaction Classification System

         

Pharmaceutical Information
Drug Name Hydrocortisone valerate
Drug ID BADD_D01092
Description Not Available
Indications and Usage For the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. Also used to treat endocrine (hormonal) disorders (adrenal insufficiency, Addisons disease). It is also used to treat many immune and allergic disorders, such as arthritis, lupus, severe psoriasis, severe asthma, ulcerative colitis, and Crohn's disease.
Marketing Status approved; vet_approved
ATC Code Not Available
DrugBank ID DB14544
KEGG ID D02288
MeSH ID C038363
PubChem ID 5282494
TTD Drug ID Not Available
NDC Product Code 68462-575; 52128-136; 68180-954; 46204-0689; 82298-116; 64958-0080; 45802-455; 0713-0560; 0713-0720; 82298-115; 68462-836; 51672-1290; 51672-1292; 59929-456
UNII 68717P8FUZ
Synonyms hydrocortisone valerate | Westcort
Chemical Information
Molecular Formula C26H38O6
CAS Registry Number 57524-89-7
SMILES CCCCC(=O)OC1(CCC2C1(CC(C3C2CCC4=CC(=O)CCC34C)O)C)C(=O)CO
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Application site reaction08.02.01.006; 12.07.01.006---
Atrophy08.03.04.001---
Condition aggravated08.01.03.004---
Dermatitis23.03.04.002---
Dermatitis acneiform23.02.01.004--
Dermatitis contact10.01.01.003; 12.03.01.040; 23.03.04.004---
Dry skin23.03.03.001--
Eczema23.03.04.006--
Erythema23.03.06.001---
Folliculitis11.02.01.053; 23.11.04.003--
Fungal infection11.03.05.001---
Gastrointestinal disorder07.11.01.001---
Hypertrichosis23.02.04.002--
Infection11.01.08.002---
Irritability08.01.03.011; 19.04.02.013--
Leukoderma23.05.02.001---
Miliaria23.02.03.014---
Pain08.01.08.004--
Pruritus23.03.12.001--
Rash23.03.13.001---
Rash maculo-papular23.03.13.004--
Secondary adrenocortical insufficiency05.03.04.012; 14.11.01.014---
Skin atrophy23.01.05.001--
Skin hypopigmentation23.05.02.003--
Skin irritation23.03.04.009---
Skin striae23.01.05.002---
Telangiectasia23.06.03.001; 24.03.03.003--
Skin maceration23.03.03.016---
Growth retardation05.03.02.007; 14.03.02.031; 15.03.05.016--
Skin burning sensation17.02.06.009; 23.03.03.021---
The 1th Page    1 2    Next   Last    Total 2 Pages